Literature DB >> 8943873

Dehydration of transferrin receptor-positive sickle reticulocytes during continuous or cyclic deoxygenation: role of KCl cotransport and extracellular calcium.

R S Franco1, M Palascak, H Thompson, D L Rucknagel, C H Joiner.   

Abstract

The K+ efflux that mediates sickle-cell dehydration may occur through several pathways, including two with a high capacity for mediating rapid K+ loss, KCl cotransport and the Ca(2+)-dependent K+ channel [K(Ca2+)]. The rate and pathway of red blood cell (RBC) dehydration most likely depends on cell age and hemoglobin (Hb) composition, with the presence of HbF playing an important role. Oxygenated sickle RBCs have relatively stable cell volume during incubation in vitro, whereas deoxygenated cells become dehydrated, and therefore more dense, due to activation of one or more K+ efflux pathways. In this investigation, sickle RBCs were deoxygenated either continuously or in 15-minute cycles for 4 hours, and the density increases of very young, transferrin receptor-positive (TfR+) cells and the remaining TfR- cells were determined. The contribution of KCl cotransport was estimated by replacing Cl- with NO3-. K(Ca2+) was inhibited by removal of Ca2+ or addition of charybdotoxin (ChTX). For both continuous and cyclic deoxygenation, TfR+ cells had a greater density increase when compared with TfR- cells. The lower percentage of HbF found in the TfR+ population may contribute to this difference. With continuous deoxygenation, the density shift was decreased by inhibition of K(Ca2+), but not by inhibition of KCl cotransport. With cyclic deoxygenation, the density shift was decreased in an independent, additive manner by inhibition of both pathways. Thus, cyclic deoxygenation of sickle cells under these conditions appears to activate both K(Ca2+) and the KCl cotransporter.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943873

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease.

Authors:  L De Franceschi; D Bachir; F Galacteros; G Tchernia; T Cynober; S Alper; O Platt; Y Beuzard; C Brugnara
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 2.  2015 Clinical trials update in sickle cell anemia.

Authors:  Natasha Archer; Frédéric Galacteros; Carlo Brugnara
Journal:  Am J Hematol       Date:  2015-10       Impact factor: 10.047

3.  Inhibition of eryptosis and intraerythrocytic growth of Plasmodium falciparum by flufenamic acid.

Authors:  Ravi S Kasinathan; Michael Föller; Saisudha Koka; Stephan M Huber; Florian Lang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-12-19       Impact factor: 3.000

4.  Regulation of K-Cl cotransport by Syk and Src protein tyrosine kinases in deoxygenated sickle cells.

Authors:  P Merciris; W J Claussen; C H Joiner; F Giraud
Journal:  Pflugers Arch       Date:  2003-03-21       Impact factor: 3.657

5.  Enhanced susceptibility to erythrocyte "apoptosis" following phosphate depletion.

Authors:  Christina Birka; Philipp A Lang; Daniela S Kempe; Lena Hoefling; Valerie Tanneur; Christophe Duranton; Srinivas Nammi; Guido Henke; Svetlana Myssina; Maxim Krikov; Stephan M Huber; Thomas Wieder; Florian Lang
Journal:  Pflugers Arch       Date:  2004-05-20       Impact factor: 3.657

6.  Inflammation in sickle cell disease.

Authors:  Nicola Conran; John D Belcher
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

7.  Differential oxygen sensitivity of the K+-Cl- cotransporter in normal and sickle human red blood cells.

Authors:  J S Gibson; P F Speake; J C Ellory
Journal:  J Physiol       Date:  1998-08-15       Impact factor: 5.182

8.  The Properties of Red Blood Cells from Patients Heterozygous for HbS and HbC (HbSC Genotype).

Authors:  A Hannemann; E Weiss; D C Rees; S Dalibalta; J C Ellory; J S Gibson
Journal:  Anemia       Date:  2010-10-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.